Polymedco, LLC has been awarded a national group purchasing agreement for National Group Purchasing Agreement with Premier, Inc. Effective November 1, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the PATHFAST® point-of-care (POC) analyzer and cardiac biomarker testing menu.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261110113278/en/

"Polymedco is thrilled to be named a contracted supplier to Premier Inc.," said Chris Mathews, CEO, Polymedco. " For more than 25 years, our mission has been to make early detection of life-threatening diseases more effective, accessible, affordable, and this agreement allows us to bring our PATHFAST® cardiac biomarker analyzer to even more of Premier's member health systems. We look forward to working alongside Premier's network of hospitals and providers to help improve patient compliance, support earlier diagnosis, and ultimately save more lives."

Premier is a leading technology-driven healthcare improvement company. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers and payers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Headquartered in Charlotte, N.C., Premier offers integrated data and analytics, collaboratives, supply chain solutions, advisory services and other solutions in service of our mission to improve the health of communities.

Polymedco partners with healthcare systems, payers, providers, and reference labs to develop best-in-class screening and early detection programs that can help identify life-threatening diseases earlier. We’re proud to offer a portfolio of products with exceptional performance, robust clinical evidence, and user-friendly design.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261110113278/en/